CORONARY INTERVENTIONS

Comparison of the effects of P2Y12 receptor antagonists on platelet function in patients undergoing primary PCI: a substudy of the HEAT-PPCI trial

EuroIntervention 2018;13:1931-1938 published online January 2018. DOI: 10.4244/EIJ-D-17-00408

Adeel Shahzad1*, MBBS, MRCP; Vikram Khanna2, MBBS, MRCP; Ian Kemp1, BA; Matthew Shaw1, BA; Christine Mars1, Dip HE; Robert Cooper1, MBBS, MRCP; Keith Wilson1; Nick Curzen2, BM (Hons), PhD, FRCP; Rod H. Stables1, MA (Cantab), DM (Oxon), BM, BCH (Oxon), FRCP

1. Institute of Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, United Kingdom; 2. University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

Aims: The HEAT-PPCI trial compared bivalirudin and unfractionated heparin in patients undergoing primary percutaneous coronary intervention (PPCI). The aim of this study was to report pre

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

adjunctive pharmacotherapybleedingmyocardial infarctionstemistent thrombosis

STEMI

Share on Facebook Share on Twitter Share on Linkedin